Chimerix, Inc. – CMRX

Chimerix, Inc. (NASDAQ: CMRX), relating to the proposed merger with Jazz Pharmaceuticals. Under the terms of the agreement, Chimerix shareholders will receive $8.55 per share.

To receive more information regarding the investigation of Chimerix, Inc. – CMRX please fill out the form below.